Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy

Abstract : Purpose: PP2A is a serine/threonine phosphatase critical to physiological processes, including apoptosis. Cell penetrating peptides are molecules that can translocate into cells without causing membrane damage. Our goal was to develop cell-penetrating fusion peptides specifically designed to disrupt the caspase-9/PP2A interaction and evaluate their therapeutic potential in vitro and in vivo. Experimental Design: We generated a peptide containing a penetrating sequence associated to the interaction motif between human caspase-9 and PP2A (DPT-C9h), in order to target their association. Using tumour cell lines, primary human cells and primary human breast cancer (BC) xenografts, we investigated the capacity of DPT-C9h to provoke apoptosis in vitro and inhibition of tumour growth (TGI) in vivo. DPT-C9h was intraperitonealy administered at doses from 1 to 25 mg/kg/day for 5 weeks. Relative Tumour Volume (RTV) was calculated. Results: We demonstrated that DPT-C9h specifically target caspase-9/PP2A interaction in vitro and in vivo and induced caspase-9-dependent apoptosis in cancer cell lines. DPT-C9h also induced significant TGI in BC xenografts models. The mouse-specific peptide DPT-C9 also induced TGI in lung (K-Ras model) and breast cancer (PyMT) models. DPT-C9h has a specific effect on transformed B cells isolated from chronic lymphocytic leukemia patients without any effect on primary healthy cells. Finally, neither toxicity nor immunogenic responses were observed. Conclusion: Using the cell-penetrating peptides blocking caspase-9/PP2A interactions, we have demonstrated that DPT-C9h had a strong therapeutic effect in vitro and in vivo in mouse models of tumour progression.
Type de document :
Article dans une revue
PLoS ONE, Public Library of Science, 2013, 8 (4), pp.e60816. 〈10.1371/journal.pone.0060816〉
Liste complète des métadonnées

Littérature citée [53 références]  Voir  Masquer  Télécharger

http://hal.upmc.fr/hal-01534831
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : jeudi 8 juin 2017 - 11:55:23
Dernière modification le : mercredi 3 janvier 2018 - 15:00:03
Document(s) archivé(s) le : samedi 9 septembre 2017 - 12:33:56

Fichier

journal.pone.0060816.PDF
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

Issam Arrouss, Fariba Némati, Fernando Roncal, Marie Wislez, Karim Dorgham, et al.. Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy. PLoS ONE, Public Library of Science, 2013, 8 (4), pp.e60816. 〈10.1371/journal.pone.0060816〉. 〈hal-01534831〉

Partager

Métriques

Consultations de la notice

238

Téléchargements de fichiers

34